Evidence map›Paper›PMID 40589497›Full record

ArticleVirus evolution2025

Unravelling dengue serotype 3 transmission in Brazil: evidence for multiple introductions of the 3III_B.3.2 lineage.

James Siqueira Pereira, Svetoslav Nanev Slavov, Isabela Carvalho Brcko, Gabriela Ribeiro, Vinicius Carius de Souza, Igor Santana Ribeiro, Iago Trezena T De Lima, Gleissy Adriane Lima Borges, Katia Cristina de Lima Furtado, Shirley Moreira da Silva Chagas and 10 more

Abstract read
In one paragraph

Article in Virus evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

James Siqueira PereiraCentro para Vigilância Viral e Avaliação Sorológica (CeVIVAS), Instituto Butantan, Av. Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.ORCID https://orcid.org/0000-0003-1893-8956
Svetoslav Nanev SlavovCentro para Vigilância Viral e Avaliação Sorológica (CeVIVAS), Instituto Butantan, Av. Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.
Isabela Carvalho BrckoCentro para Vigilância Viral e Avaliação Sorológica (CeVIVAS), Instituto Butantan, Av. Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.
Gabriela RibeiroCentro para Vigilância Viral e Avaliação Sorológica (CeVIVAS), Instituto Butantan, Av. Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.
Vinicius Carius de SouzaCentro para Vigilância Viral e Avaliação Sorológica (CeVIVAS), Instituto Butantan, Av. Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.
Igor Santana RibeiroCentro para Vigilância Viral e Avaliação Sorológica (CeVIVAS), Instituto Butantan, Av. Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.
Iago Trezena T De LimaCentro para Vigilância Viral e Avaliação Sorológica (CeVIVAS), Instituto Butantan, Av. Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.
Gleissy Adriane Lima BorgesLaboratório Central de Saúde Pública do Estado do Pará (LACEN-PA), Rodovia Augusto Montenegro, 524, Belém, PA 66823-010, Brazil.
Katia Cristina de Lima FurtadoLaboratório Central de Saúde Pública do Estado do Pará (LACEN-PA), Rodovia Augusto Montenegro, 524, Belém, PA 66823-010, Brazil.
Shirley Moreira da Silva ChagasLaboratório Central de Saúde Pública do Estado do Pará (LACEN-PA), Rodovia Augusto Montenegro, 524, Belém, PA 66823-010, Brazil.
Patricia Miriam Sayuri Sato Barros da CostaLaboratório Central de Saúde Pública do Estado do Pará (LACEN-PA), Rodovia Augusto Montenegro, 524, Belém, PA 66823-010, Brazil.
Talita Émile Ribeiro AdelinoLaboratório Central de Saúde Pública do Estado de Minas Gerais (LACEN-MG), Fundação Ezequiel Dias, Rua Conde Pereira Carneiro, 80, Belo Horizonte, MG 30510-010, Brazil.
Felipe C de Melo IaniLaboratório Central de Saúde Pública do Estado de Minas Gerais (LACEN-MG), Fundação Ezequiel Dias, Rua Conde Pereira Carneiro, 80, Belo Horizonte, MG 30510-010, Brazil.
Luiz Carlos Junior AlcantaraInstituto Rene Rachou, Fundação Oswaldo Cruz, Av. Augusto de Lima, 1715 - Barro Preto, Belo Horizonte, MG 30190-002, Brazil.
Verity HillDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, College Street, 60, New Haven, CT 06510, United States.
Nathan D GrubaughDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, College Street, 60, New Haven, CT 06510, United States.
Sandra Coccuzzo SampaioCentro para Vigilância Viral e Avaliação Sorológica (CeVIVAS), Instituto Butantan, Av. Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.
Maria Carolina EliasCentro para Vigilância Viral e Avaliação Sorológica (CeVIVAS), Instituto Butantan, Av. Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.ORCID https://orcid.org/0000-0002-0501-8280
Marta GiovanettiCentro para Vigilância Viral e Avaliação Sorológica (CeVIVAS), Instituto Butantan, Av. Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.ORCID https://orcid.org/0000-0002-5849-7326
Alex Ranieri J LimaCentro para Vigilância Viral e Avaliação Sorológica (CeVIVAS), Instituto Butantan, Av. Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.ORCID https://orcid.org/0000-0002-5283-7502

Funding

Enhancing dengue virus genomic surveillance to uncover circulating genetic diversityDP2AI176740 · NIAID · YALE UNIVERSITY · PI GRUBAUGH, NATHAN DALE · 2022 to 2025
$2.5M
NIAID NIH HHS DP2 AI176740
6 · The paper itself

Abstract

Dengue, caused by dengue virus (DENV) 1-4, remains a global public health concern, with Brazil experiencing some of the largest epidemics. The re-emergence of DENV-3 in Brazil between 2023 and 2024 has raised concerns about new outbreaks due to the absence of sustained circulation of this serotype in recent years. This study investigates the dynamics of DENV-3 in Brazil, focusing on the spread of the 3III_B.3.2 lineage within genotype 3III and its introduction routes. We analysed 1536 DENV-3 genomes, including 11 newly generated in this study, all classified as genotype 3III, the dominant DENV-3 genotype in Brazil since 2001. Phylogenetic analysis identified the 3III_B.3.2 lineage in all recent Brazilian cases, with detections also reported in Central America, the USA, and Europe. At least six independent introduction events of this lineage into Brazil were identified, with the Caribbean region as the primary source. The earliest introduction likely occurred in late 2022 in Roraima, followed by introductions in São Paulo, Minas Gerais, and Pará. While one instance of interstate transmission was detected-from São Paulo to Minas Gerais-our findings indicate that external introductions, rather than domestic spread, were the primary drivers of DENV-3 circulation during this period. These results underscore the importance of continued genomic surveillance and coordinated public health strategies to monitor and mitigate future outbreaks.

Indexed as

dengue lineagegenomic surveillanceoutbreakphylogeography

Identifiers

PMID40589497
PMCPMC12208352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.